Journal of Cancer Science & Therapy is pleased to announce Special issue on the topic “Cancer history: A severe risk factor in Covid-19 patients”.
With the available global data on spread of corona virus and mortality rate in Covid-19 patients, there has been an increased risk in expression of the symptoms and mortality in patients with cancer history or patients undergoing cancer treatment. The incidence of COVID-19 in patients with cancer would be more informative in assessing whether or not patients with cancer have an increased risk of COVID-19. Additionally, there are reports that patients with cancer were prone to severe events (admission to the intensive care unit requiring invasive ventilation, or death) from COVID-19. Evidence indicates that overwhelming inflammation and cytokine-associated lung injury could be important in instigating these severe events in patients with COVID-19.
In the process of making more information available about this topic on an open access platform, Journal of Cancer Science & Therapy would like to invite all the Researchers/Doctors/Medical Professionals/Institutions to submit Case-report, research, review, short commentary, opinion, perspective or any kind of article related to the topic and it will be processed within the next 15 days and published in our May month special issue.
Please visit Instruction for authors page to know more about article formatting and guidelines: https://www.hilarispublisher.com/cancer-science-therapy/instructionsforauthors.html